Key result
NSAID use is not associated with increased 24-month mortality in acute myocarditis.
Why the study?
Animal studies linked NSAIDs to adverse outcomes in acute myocarditis, leading to recommendations against their use, but clinical evidence on their effects in patients remained needed.
Does NSAID treatment worsen outcomes in patients with acute myocarditis or myopericarditis?
Case-Control (n=114)
No
Does NSAID treatment worsen outcomes in patients with acute myocarditis or myopericarditis?
In a retrospective case-control study, NSAID use in acute myocarditis was not associated with increased mortality or worse left ventricular function, suggesting they may be safe despite current recommendations.
Answers are grounded in this paper and cite their sources.
NSAIDs were not linked to higher mortality in acute myocarditis; hypothesis-generating and should not yet change practice.
Background: Previous animal studies reported an association of non-steroidal anti-inflammatory drugs (NSAIDs) with adverse outcomes in acute myocarditis, which is why these drugs are currently not recommended in affected patients. In this retrospective case-control study, we sought to investigate the effects of NSAID treatment in patients with acute myocarditis and myopericarditis to complement the available evidence. Method: A total of 114 patients with acute myocarditis were retrospectively enrolled. Demographical, clinical and laboratory data were extracted from hospital records. Patients who received NSAIDs (n = 39, 34.2%) were compared to controls. Follow-up on all-cause mortality was acquired for two years. Propensity score matching was additionally conducted to account for covariate imbalances between groups. Results: Treatment with NSAIDs was neither associated with a worse outcome (p = 0.115) nor with significant differences in left ventricular systolic function (p = 0.228) or in-hospital complications (p = 0.507). Conclusion: Treatment with NSAIDs was not associated with adverse outcomes in our study cohort. Together with the findings of previous studies, our results indicate that these drugs could be safely administered in patients with myocarditis and myopericarditis.
No takes yet. Share an insight, caveat, or question.
Mirna et al. (2022) conducted a case-control in Acute myocarditis and myopericarditis (n=114). Non-steroidal anti-inflammatory drugs (NSAIDs) vs. No NSAIDs (Standard care) was evaluated on All-cause mortality within 24 months (p=0.115). Treatment with NSAIDs was not associated with an increased risk of 24-month all-cause mortality in patients with acute myocarditis or myopericarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: